Morgan Stanley’s Medicenna Therapeutics Corp. Common Shares MDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,800
| Closed | -$531 | – | 8024 |
|
|
2023
Q3 | $531 | Hold |
1,800
| – | – | ﹤0.01% | 7300 |
|
|
2023
Q2 | $867 | Hold |
1,800
| – | – | ﹤0.01% | 7318 |
|
|
2023
Q1 | $1.13K | Hold |
1,800
| – | – | ﹤0.01% | 7335 |
|
|
2022
Q4 | $824 | Hold |
1,800
| – | – | ﹤0.01% | 7494 |
|
|
2022
Q3 | $1K | Sell |
1,800
-200,000
| -99% | -$111K | ﹤0.01% | 7639 |
|
|
2022
Q2 | $234K | Buy |
201,800
+197,981
| +5,184% | +$230K | ﹤0.01% | 5818 |
|
|
2022
Q1 | $5K | Sell |
3,819
-3,521
| -48% | -$4.61K | ﹤0.01% | 7603 |
|
|
2021
Q4 | $12K | Sell |
7,340
-31,265
| -81% | -$51.1K | ﹤0.01% | 7426 |
|
|
2021
Q3 | $107K | Sell |
38,605
-25,000
| -39% | -$69.3K | ﹤0.01% | 6335 |
|
|
2021
Q2 | $192K | Sell |
63,605
-3,993
| -6% | -$12.1K | ﹤0.01% | 6040 |
|
|
2021
Q1 | $276K | Buy |
67,598
+57,868
| +595% | +$236K | ﹤0.01% | 5474 |
|
|
2020
Q4 | $45K | Buy |
9,730
+8,430
| +648% | +$39K | ﹤0.01% | 6192 |
|
|
2020
Q3 | $5K | Buy |
+1,300
| New | +$5K | ﹤0.01% | 6456 |
|